Christopher Dodd actually said...

Strong enforcement promotes investor confidence and participation in these markets.

I cannot remember a time when the need for strong, independent leadership at the FDA was more critical.

I know of no dissenting voices.

I regret we do not now. It would have been a very different situation, in many ways, if we had such.